L-708906
L-708906 is a potent human immunodeficiency virus type 1 (HIV-1) inhibitor with an IC50 value of 12 μM. L-708906 inhibits HIV strains resistant to nonnucleoside or nucleoside reverse transcriptase inhibitors.
For research use only. We do not sell to patients.
- CAS No.: 251963-74-3
- Formula: C24H20O6
- Molecular Weight:404.41
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HeLa | EC50 |
0.78 μM
Compound: L-708906
|
Antiviral activity against human immuno deficiency virus type 1 in HeLa H1-JC.37 cells
Antiviral activity against human immuno deficiency virus type 1 in HeLa H1-JC.37 cells
|
[PMID: 15999991] |
| MOLT-4 | EC50 |
5.7 μM
Compound: L-706908
|
Antiviral activity against Human immunodeficiency virus 1 3B infected in human MOLT4 assessed as inhibition of viral replication after 5 days by reverse transcriptase assay
Antiviral activity against Human immunodeficiency virus 1 3B infected in human MOLT4 assessed as inhibition of viral replication after 5 days by reverse transcriptase assay
|
[PMID: 21371895] |
| MOLT-4 | EC50 |
5.7 μM
Compound: L-706908
|
Antiviral activity against HIV1 LAI replication in MOLT4 cells
Antiviral activity against HIV1 LAI replication in MOLT4 cells
|
[PMID: 17158051] |
| MT4 | CC50 |
>50 μM
Compound: 2, (L-708906)
|
Cytotoxic concentration was measured against MT-4 human T-lymphoid cells
Cytotoxic concentration was measured against MT-4 human T-lymphoid cells
|
[PMID: 12643946] |
| MT4 | CC50 |
62 μM
Compound: L-706908
|
Cytotoxicity against human MT4 cells by MTT assay
Cytotoxicity against human MT4 cells by MTT assay
|
[PMID: 18541726] |
| MT4 | EC50 |
12.4 μM
Compound: L-706908
|
Antiretroviral activity against Human immunodeficiency virus 1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay
Antiretroviral activity against Human immunodeficiency virus 1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay
|
[PMID: 18541726] |
| MT4 | EC50 |
12.4 μM
Compound: L-706908
|
Antiviral activity against Human immunodeficiency virus 1 3B infected in human MT4 cells assessed as inhibition of viral replication
Antiviral activity against Human immunodeficiency virus 1 3B infected in human MT4 cells assessed as inhibition of viral replication
|
[PMID: 18541726] |
| MT4 | EC50 |
19.3 μM
Compound: L-706908
|
Antiviral activity against non nucleoside reverse transcriptase inhibitor-resistant Human immunodeficiency virus 1 infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay
Antiviral activity against non nucleoside reverse transcriptase inhibitor-resistant Human immunodeficiency virus 1 infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay
|
[PMID: 18541726] |
| MT4 | EC50 |
22.6 μM
Compound: L-706908
|
Antiretroviral activity against Simian immunodeficiency virus MAC 251 infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay
Antiretroviral activity against Simian immunodeficiency virus MAC 251 infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay
|
[PMID: 18541726] |
| MT4 | EC50 |
24.5 μM
Compound: L-706908
|
Antiretroviral activity against Human immunodeficiency virus 1 NL4.3 infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay
Antiretroviral activity against Human immunodeficiency virus 1 NL4.3 infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay
|
[PMID: 18541726] |
| MT4 | EC50 |
62.1 μM
Compound: L-706908
|
Antiretroviral activity against Human immunodeficiency virus 2 ROD infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay
Antiretroviral activity against Human immunodeficiency virus 2 ROD infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay
|
[PMID: 18541726] |
| MT4 | EC50 |
7.2 μM
Compound: L-706908
|
Antiviral activity against Reverse transcriptase inhibitor-resistant Human immunodeficiency virus 1 infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay
Antiviral activity against Reverse transcriptase inhibitor-resistant Human immunodeficiency virus 1 infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay
|
[PMID: 18541726] |
| MT4 | EC50 |
7.4 μM
Compound: L-706908
|
Antiviral activity against Protease inhibitor-resistant Human immunodeficiency virus 1 infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay
Antiviral activity against Protease inhibitor-resistant Human immunodeficiency virus 1 infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay
|
[PMID: 18541726] |
| MT4 | IC50 |
1.9 μM
Compound: 2, (L-708906)
|
Antiviral potency was measured in HIV-1IIIb infected MT-4 human T-lymphoid cells
Antiviral potency was measured in HIV-1IIIb infected MT-4 human T-lymphoid cells
|
[PMID: 12643946] |
Chemical Information
-
CAS No. 251963-74-3
-
Molecular Weight 404.41
-
Formula C24H20O6
-
SMILES
O=C(C(CC(C1=CC(OCC2=CC=CC=C2)=CC(OCC3=CC=CC=C3)=C1)=O)=O)O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)